Exploring the mechanism of levocarnitine in the treatment of epididymitis based on network pharmacology and molecular docking technology

CONCLUSION: This study revealed through network pharmacology that levocarnitine may act on multiple signaling pathways by targeting AKT1, HSP90AA1, ALB, CASP3, GSK3B, GSR, etc., thereby potentially exerting therapeutic effects on epididymitis.PMID:38619515

Source: Atherosclerosis - April 15, 2024 Category: Cardiology Authors: Ming-Wei Zhan Lei Wang Xu-Xin Zhan Peng-Fei Liu Qiang Lou Yu-Qi Lai Yi Yu Xue-Jun Shang Source Type: research